Related references
Note: Only part of the references are listed.Biological evaluation and molecular docking studies of 4-aminobenzohydrazide derivatives as cholinesterase inhibitors
Zuleyha Almaz et al.
JOURNAL OF MOLECULAR STRUCTURE (2021)
Design, synthesis, and biological evaluation of novel xanthone-alkylbenzylamine hybrids as multifunctional agents for the treatment of Alzheimer's disease
Zhipeng Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Characterization and analysis of antioxidant activity of walnut-derived pentapeptide PW5 via nuclear magnetic resonance spectroscopy
Min Wang et al.
FOOD CHEMISTRY (2021)
Discovery of Guanidine Derivatives from Buthus martensii Karsch with Metal-Binding and Cholinesterase Inhibition Properties
Yu-Ming Liu et al.
MOLECULES (2021)
Design and development of novel p-aminobenzoic acid derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer's disease
Sushant K. Shrivastava et al.
BIOORGANIC CHEMISTRY (2019)
Assessment of novel azaanthraquinone derivatives as potent multi-target inhibitors of inflammation and amyloid-β aggregation in Alzheimer's disease
Juan Wang et al.
BIOORGANIC CHEMISTRY (2019)
Chlorinated tacrine analogs: Design, synthesis and biological evaluation of their anti-cholinesterase activity as potential treatment for Alzheimer's disease
Hanan M. Ragab et al.
BIOORGANIC CHEMISTRY (2019)
Design, synthesis, evaluation and molecular modeling study of 4-N-phenylaminoquinolines for Alzheimer disease treatment
Jun Zhu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Synthesis of novel Schiff bases and azol-β-lactam derivatives starting from morpholine and thiomorpholine and investigation of their antitubercular, antiurease activity, acethylcolinesterase inhibition effect and antioxidant capacity
Yildiz Uygun Cebeci et al.
BIOORGANIC CHEMISTRY (2019)
New 4-N-phenylaminoquinoline derivatives as antioxidant, metal chelating and cholinesterase inhibitors for Alzheimer's disease
Rong Cai et al.
BIOORGANIC CHEMISTRY (2019)
Conventional and microwave prompted synthesis, antioxidant, anticholinesterase activity screening and molecular docking studies of new quinolone-triazole hybrids
Arif Mermer et al.
BIOORGANIC CHEMISTRY (2018)
Isosteroidal alkaloids as potent dual-binding site inhibitors of both acetylcholinesterase and butyrylcholinesterase from the bulbs of Fritillaria walujewii
Yu-Ming Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis, docking study and neuroprotective effects of some novel pyrano[3,2-c]chromene derivatives bearing morpholine/phenylpiperazine moiety
Bilqees Sameem et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Oxidative stress, protein modification and Alzheimer disease
A. Tramutola et al.
BRAIN RESEARCH BULLETIN (2017)
Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease
Sultan Darvesh
CURRENT ALZHEIMER RESEARCH (2016)
Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids as Multifunctional Drug Candidates against Alzheimer's Disease
Yingbo Fu et al.
MOLECULES (2016)
iLOGP: A Simple, Robust, and Efficient Description of n-Octanol/Water Partition Coefficient for Drug Design Using the GB/SA Approach
Antoine Daina et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands
Jonah Cheung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Targeting Alzheimer's disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238
Stefano Rizzo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Synthesis of new N-isobutyryl-L-cysteine/MEA conjugates:: Evaluation of their free radical-scavenging activities and anti-HIV properties in human macrophages
Michael Smietana et al.
BIOORGANIC CHEMISTRY (2008)
Oxidative stress hypothesis in Alzheimer's disease: a reappraisal
Domenico Pratico
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Impact of the amount of excess solids on apparent solubility
K Kawakami et al.
PHARMACEUTICAL RESEARCH (2005)
The Nrf2-ARE Signalling Pathway: Promising Drug Target to Combat Oxidative Stress in Neurodegenerative Disorders
Freek L. van Muiswinkel et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2005)
Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products
Y Nicolet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
